Kakkalide

CAS No. 58274-56-9

Kakkalide( —— )

Catalog No. M24574 CAS No. 58274-56-9

Kakkalide is a potent lactate dehydrogenase (LDH) inhibitor, it has anti-inflammatory effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 375 In Stock
10MG 560 In Stock
25MG 893 In Stock
50MG 1197 In Stock
100MG 1602 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Kakkalide
  • Note
    Research use only, not for human use.
  • Brief Description
    Kakkalide is a potent lactate dehydrogenase (LDH) inhibitor, it has anti-inflammatory effects.
  • Description
    Kakkalide is a potent lactate dehydrogenase (LDH) inhibitor, it has anti-inflammatory effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    LDH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58274-56-9
  • Formula Weight
    608.6
  • Molecular Formula
    C28H32O15
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C1C2=C(O)C(OC)=C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)CO[C@H]4[C@@H]([C@H]([C@H](O)CO4)O)O)C=C2OC=C1C5=CC=C(OC)C=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kakkalide ameliorates endothelial insulin resistance by suppressing reactive oxygen species-associated inflammation.J Diabetes. 2013 Mar;5(1):13-24.
molnova catalog
related products
  • Trilostane

    Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome.

  • Mutant IDH1 inhibito...

    Mutant IDH1 inhibitor is an effective inhibitor of mutant IDH1 R132H (IC50: < 72 nM).

  • SCD1 inhibitor-3

    SCD1 inhibitor-3 (ML-270) is a highly effective and orally available compound that inhibits SCD1 with remarkable safety.